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Abstract
Toxoplasma gondii infects humans and warm blooded animals causing devastating disease worldwide. It has long been a
mystery as to why the peritoneal macrophages of rats are naturally resistant to T. gondii infection while those of mice are
not. Here, we report that high expression levels and activity of inducible nitric oxide synthase (iNOS) and low levels of
arginase-1 (Arg 1) activity in the peritoneal macrophages of rats are responsible for their resistance against T. gondii
infection, due to high nitric oxide and low polyamines within these cells. The opposite situation was observed in the
peritoneal macrophages of mice. This discovery of the opposing functions of iNOS and Arg 1 in rodent peritoneal
macrophages may lead to a better understanding of the resistance mechanisms of mammals, particularly humans and
livestock, against T. gondii and other intracellular pathogens.
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Introduction
Persistent infection is one hallmark of the Apicomplexan
protozoan Toxoplasma gondii, and it is required for maintaining
the parasite’s life cycle. This feature and the ability to infect a
broad spectrum of warm-blooded vertebrates, including up to
30% of the world’s human population, as well as to develop within
any nucleated cell type investigated so far, shows T. gondii to be one
of the most successful obligate intracellular parasites [1]. In most
human infected individuals, infection is often asymptomatic and
develops into a dormant parasite stage which persists in brain and
muscle tissues. T. gondii is also a major opportunistic pathogen of
fetuses from recently infected mothers, and of immunocompro-
mised patients, i.e. those with organ transplantation and AIDS
[2,3]. In these individuals, the immune system is unable to control
the parasite efficiently, leading to unrestricted parasite multiplica-
tion and to life-threatening disease.
Rats are naturally resistant to T. gondii, in contrast to other
rodent mammals such as mice, guinea pigs and hamsters [1,4,5].
T. gondii does not proliferate in rat peritoneal macrophages in vitro,
but easily proliferates in peritoneal macrophages of susceptible
hosts, such as mice [6]. McCabe and Remington (1986)
demonstrated that freshly cultured rat macrophages killed more
than 90% of the T. gondii ingested and that the surviving T. gondii
did not replicate when they were observed for up to 72 hrs after
ingestion [7]. However, the mechanism of rat macrophage
resistance to T. gondii remains yet to be determined.
When stimulated with Th1 cytokines [8] or with microbe-
derived products [9–11], mouse macrophages express the
inducible nitric oxide synthase (iNOS), which synthesizes large
amounts of nitric oxide (NO) through oxidation of L-arginase. NO
is known to be a major effector molecule in macrophage-mediated
cytotoxicity and therefore the macrophage-derived NO has been
considered a key component of its defense against microbial agents
[12], including Toxoplasma [13–15]. Interestingly, T. gondii can
easily infect and proliferate in mouse macrophages and reduce
their NO production [16,17].
Arginase shares the same substrate (i.e. L-arginine) with iNOS.
Two isoforms of arginase have been identified from macrophages
of rat and mouse. Cytoplasmic arginase I and mitochondrial
arginase II catalyze the same reaction [18]. Arginase hydrolyzes L-
arginine to L-ornithine and urea. L-ornithine favors parasite
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growth and is the precursor for the synthesis of L-glutamine, L-
proline and polyamines via the ornithine decarboxylase (ODC)
pathway. Polyamines are essential for the proliferation of cells and
parasites [19–21]. Furthermore, the potential pathological effects
of high NO throughput are limited because arginase competes
with iNOS for the same substrate, and it has been established that
arginase activity modulates NO production by reducing the
availability of L-arginine to iNOS [22,23].
It has long been known that rat macrophages are naturally
resistant to T. gondii infection. However, the mechanism of this
resistance has not been reported. Many studies have demonstrated
that NO can inhibit T. gondii proliferation in mouse macrophages
after being stimulated with LPS or other cytokines [13,15]. It has
also been shown that in rat and mouse, NOS and arginase activity
levels are different in resident peritoneal macrophages [24].
Herein, we raise the questions of whether NO in rat macrophages
plays a key role in their resistance to T. gondii infection and
whether there is any interaction between arginase and iNOS in the
rat macrophage that could explain the rat’s resistance to T gondii
infection. The aim of this study is to investigate whether host
iNOS and arginase are opposing markers of resistance/suscepti-
bility to T. gondii infection in rodent macrophages
Results
The levels of iNOS expression and NO production are
high in rat peritoneal macrophages compared to
undetectable levels in mouse macrophages
Since there is competition for the substrate (arginine) between
iNOS and arginase, we analyzed the level of iNOS expression and
NO production in non-activated peritoneal macrophages isolated
from 5 strains of rat (Sprague-Dawley (SD), Lewis, Wistar, F344
and Brown Norway (BN)) and 4 strains of mouse (Swiss, BALB/c,
C57BL/6 and NIH). Compared to the non-detectable iNOS
mRNA expression in mouse peritoneal macrophages, high levels
of iNOS mRNA was found in rat peritoneal macrophages
(Figure 1A). Among the 5 strains of rat examined, the highest
iNOS expression level was observed in the Lewis rat, while the
lowest was found in the BN rat. However, iNOS mRNA
expression could not be detected in the macrophages from the 4
mouse strains (Fig. 1A). Results from Western blot analysis
demonstrated higher expression of iNOS protein in Lewis and SD
rats, with lower expression in the other three rat strains, while
none was detected in mouse macrophages (Fig. 1B). The
concentration of NO in the culture media for the rodent peritoneal
macrophages was also measured by the Griess method [25]. In
contrast to the undetectable NO in the media from cultivated
mouse macrophages, large amounts of NO were detected in the
media from cultivation of rat macrophages (25.4261.08 mM from
Lewis rat at 24 hrs) (Fig. 1C). These results are consistent with
previous findings that Lewis rat peritoneal macrophages could
produce large amounts of NO, while C57BL/6 mouse peritoneal
macrophages generated barely detectable traces [26].
Rat peritoneal macrophages are resistant to the T. gondii
RH strain while mouse macrophages are susceptible to
this parasite
Existing evidence suggests that mouse peritoneal macrophages
support the growth of T. gondii. We tested this hypothesis by
measuring the proliferation of T. gondii in non-activated rat and
mouse peritoneal macrophages (Fig. 2). Our results indicated that
the T. gondii RH strain (Type I virulent strain) grew dramatically
after 24 hrs infection in mouse peritoneal macrophages in vitro; in
contrast, a significantly lower number of T. gondii were found in rat
peritoneal macrophages (Fig. 2A). These results confirm previous
studies [6,7] and demonstrate the comparability of our system.
Through fluorescent microscopy and Wright-Giemsa staining of
infected cells, we found that after 24 hrs of T. gondii infection there
were, on average, only one or two parasites in rat macrophages
compared to more than 14 parasites in mouse cells, indicating that
rat macrophages exhibit high resistance to T. gondii (Figs. 2B and
2C). Interestingly, a greater number of parasites were found in the
peritoneal macrophages from the BN rat in which we detected a
lower level of NO (Fig. 2A). The BN rat has been reported to be
more sensitive to other strains of T. gondii, such as the Prugniaud
strain [27,28]. Accordingly, we hypothesized that NO could be an
important factor involved in rat peritoneal macrophage resistance
against T. gondii infection. This also supports studies showing the
effect of NO against pathogens including T. gondii in a mouse
model system.
T. gondii proliferation is inhibited in NO-induced
macrophages and promoted in NO-decreased cells
To characterize the role of NO in resistance to T. gondii, we
infected rat and mouse cells treated with NO inducer IFN-c+LPS
and iNOS inhibitor NG -nitro-L-arginine methylester (L-NAME).
The expression level of the iNOS gene in mouse (Fig. 3A) and rat
(Fig. 3D) macrophages activated by LPS+IFN-c was significantly
higher than in non-activated control cells. A significant increase of
NO concentration was detected in all groups of mouse (Fig. 3B)
and rat (Fig. 3E) peritoneal macrophages treated with LPS+IFN-c,
while a much lower NO concentration was observed in all strains
of rat peritoneal macrophages treated with L-NAME (Fig. 3E).
The growth of T. gondii was significantly inhibited in NO-induced
mouse macrophages (Fig. 3C). Although the difference in parasite
numbers in the macrophages of SD, Wistar and Lewis rats was not
closely associated with LPS+IFN-c treatment, great discrepancies
were found in the peritoneal macrophages of rat strains F344 and
BN (Fig. 3F). These results can be attributed to the innate high
concentration of NO in Lewis, SD, and Wistar rats which is high
enough to inhibit the replication of T. gondii and thereby conceal
further effects caused by the treatment with LPS+IFN-c. However,
a greater number of parasites were found within the NO-
decreased rat peritoneal macrophages treated with L-NAME
(Fig. 3F).
Rats are naturally resistant to T. gondii, while mice are
highly susceptible
We further tested the susceptibility of different strains of mouse
and rat to the T. gondii RH strain, in order to confirm and extend
previous studies [28–32]. For two months following inoculation,
no deaths were observed in any strains of rat tested, including one-
week-old suckling rats infected with 106 tachyzoites of RH strain
(intra-peritoneally) (Fig. 4A). Parasites were not detected in the
brain, heart, liver, lungs, or kidneys of the infected rats either by
inoculation of the organ homogenates into mice or by PCR at 2
months post-infection. However, all strains of mouse tested died
from the infection within 3 to 5 days post-inoculation with the
same T. gondii RH strain. Furthermore, a large number of parasites
were found in the above-mentioned organs, taken from the
infected mice, by microscopic examination (Fig. 4B). These results
further confirm that rats, including newborns, are naturally
resistant to the RH strain of T. gondii, while mice are highly
susceptible to fatal infection [29].
Mechanism of Rat Resistance to T. gondii
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The level of arginase-1 expression and arginase activity is
much higher in mouse peritoneal macrophages than that
in rat macrophages
We compared arginase-1 expression and arginase activity in rat
and mouse peritoneal macrophages. Our results showed that the
level of arginase-1 mRNA expression in macrophages from four
strains of mouse was very high, compared to that in macrophages
from five strains of rat (Fig. 5A). Western blot results also indicated
that the level of arginase-1 protein expression was much higher in
mouse macrophages than in rat cells (Fig. 5B). We examined
arginase activity in rat and mouse macrophages and found that
mouse macrophages produce high arginase activity
(15.860.9 mmol urea/mg protein from C57BL/6 mouse), com-
pared to rat peritoneal macrophages (0.1660.037 mmol urea/mg
protein from SD rat) (Fig. 5C).
Levels of iNOS and arginase-1 and the growth of T. gondii
in peritoneal macrophages from BN, Lewis and BN6
Lewis F1 progeny
Our previous data show that among the 5 strains of rat, the
expression level of iNOS is highest in Lewis macrophages and
lowest in BN macrophages. We therefore decided to ascertain
whether any difference in mRNA expression level of iNOS and
arginase-1 occurs between BN, Lewis and the F1 progeny of BN6
Lewis. The iNOS expression level and NO concentration in the
peritoneal macrophages from F1 progeny of BN6Lewis was
significantly lower than that of Lewis but higher than that in BN
rats. Furthermore, the arginase activity in BN6Lewis was higher
than that of Lewis but lower than that in BN rats (Figs. 6A, 6B and
6C). We then examined the growth rate of T. gondii RH strain in
the peritoneal macrophages from the F1 progeny of BN6Lewis,
and found that the number of parasites in the F1 peritoneal
macrophages was significantly higher than those from Lewis rats
but much lower than those from BN rats. From 0 hr to 48 hrs
post-infection, compared to the high levels of growth of T. gondii in
BN rat macrophages and the absence of T. gondii in Lewis rat
macrophages, there was no significant difference in the parasite
numbers at 0 hr, 12 hrs and 48 hrs after infection (p.0.05),
indicating that the ability to restrict parasite growth in the F1
progeny of BN6Lewis is higher than in BN but lower than in
Lewis (Fig. 6D).
Proliferation of T. gondii is restricted in arginase-inhibited
mouse macrophages treated with norNOHA
Given that arginase activity in mouse macrophages is very high,
we wanted to investigate the growth of T. gondii in mouse
macrophages in which arginase activity is inhibited by norNOHA.
Figure 1. Inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production in peritoneal macrophages from 5 rat
strains (Sprague-Dawley, Wistar, Brown Norway, F344, and Lewis) and 4 mouse strains (Swiss, BALB/c, C57BL/6, and NIH). (A) (Top)
RT-PCR analysis for the expression of iNOS mRNA. (Bottom) Amplicons were densitometrically quantified; bars represent relative amounts of
amplified iNOS mRNA normalized against GAPDH. (B) (Top) Western blotting analysis for the expression of iNOS protein. (Bottom) The protein bands
were densitometrically quantified and the relative amounts of amplified iNOS protein normalized against tubulin. (C) Comparison of NO production,
measured by the Griess reaction, in rat and mouse macrophages. Error bars indicate standard deviations of the measured values (n = 3). One-way
ANOVA test to compare any significant differences of NO production among all kinds of groups and different letters above the same bar type indicate
significant difference (Duncan, p,0.05). Student’s t-test was used to compare differences between 12 hrs and 24 hrs and statistical differences of NO
concentrations between 12 hrs and 24 hrs for each strain were designated by *(p,0.05). ND: not detectable (n = 3).
doi:10.1371/journal.pone.0035834.g001
Mechanism of Rat Resistance to T. gondii
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norNOHA was shown by us, both in vitro and in vivo, that it had no
effect on the growth of Toxoplasma (Data not shown). Figure 7A
shows that arginase activity is significantly decreased in LPS+nor-
NOHA co-treated cells, compared to those LPS-treated only or to
control cells. We then found that NO concentration was
significantly higher in LPS+norNOHA co-treated mouse macro-
phages, compared to the low NO level in the LPS-treated only or
control cells (p,0.01). There is no significant difference in NO
level between LPS-treated and control cells (p.0.05). These data
showed that when arginase activity was inhibited, it could promote
NO production (Fig. 7B). We further demonstrated that, in
contrast to control cells at 0 hr infection, the number of T. gondii/
100 cells was significantly decreased in LPS+norNOHA co-treated
cells (P,0.01). At 18 hrs post-infection, the number of T. gondii per
100 cells was also significantly lower in LPS+norNOHA co-treated
macrophages, compared to LPS-treated only or control cells.
These results showed that the inhibition of arginase activity
reduced the infection and proliferation of T. gondii in mouse
macrophages (Fig. 7C).
Figure 2. Comparison of Toxoplasma gondii proliferation in Sprague-Dawley rat and BALB/c mouse macrophages. (A) Number of T.
gondii per 100 macrophages counted 0 hr and 24 hrs after infection. Error bars indicate standard deviations of the measured values. One-way ANOVA
test to compare any significant differences of parasite numbers among all kinds of groups and different letters above the same bar type indicate
significant difference (Duncan, p,0.05). Student’s t-test was used to compare differences between 0 hr and 24 hrs and statistical differences of
numbers of infected parasites per 100 cells for each strain between 0 hr and 24 hrs were designated by *(p,0.05), ** (p,0.01) and *** (p,0.001). (B)
Analysis of T. gondii proliferation in macrophages by fluorescent microscopy. (C) Cells from Fig. 2B stained with Wright-Giemsa 24 hrs after infection
(n = 5).
doi:10.1371/journal.pone.0035834.g002
Mechanism of Rat Resistance to T. gondii
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Discussion
Previous research has shown that rat peritoneal macrophages do
not support the multiplication of Toxoplasma gondii in vitro, but those
of mice do [6,7]. Some explanations have been suggested
regarding the mechanism that accounts for this difference, but it
is far from understood. A large number of reports have
demonstrated that NO is a major effector molecule for
macrophage-mediated cytotoxicity in mouse macrophages and is
a key anti-pathogen factor used by the infected host to control
progression of intracellular pathogens including Toxoplasma
[13,33–36]. We speculated whether there would be any difference
in NO between mouse and rat resident macrophages. Our results
show that rat peritoneal macrophages express a high level of iNOS
and produce much more NO although difference was found
within the strains of rats, whereas NO is undetectable in mouse
macrophages, which indicates that NO could be an important
factor accounting for the resistance of rat peritoneal macrophages
against T. gondii infection. We have shown that the number of
tachyzoites is significantly higher in rat macrophages treated with
L-NAME than in control cells, while the proliferation of T. gondii is
obviously inhibited in the rat or mouse macrophages treated with
LPS+IFN-c. These data demonstrate that a high concentration of
NO in rat peritoneal macrophages is closely associated with their
resistance to T. gondii infection, supporting our hypothesis that NO
in rat macrophages is linked to the resistance to T. gondii infection,
as implied in published results regarding mouse activated
macrophages [14,16,33,37,38].
Macrophages have been considered one of the key cells for
distribution of T. gondii to other organs after infection [39], and
therefore are suggested to play a part in the natural resistance of
rats against the parasite. We have confirmed the fact that rats,
even newborns, are naturally resistant to the RH strain of T. gondii,
while mice are highly susceptible to its fatal infection. Results from
the analysis of genetic recombination between BN and Lewis rats,
and their F1 progeny, have revealed that a major locus on
chromosome 10, called Toxo1, mediates resistance to T. gondii
infection [27]. It was suggested that Toxo1 is associated with the
ability of the macrophage to impede the proliferation of the
parasite in the parasitophorous vacuole [27]. We found that the
number of tachyzoites of T. gondii RH strain in the peritoneal
macrophages of the F1 progeny of BN6Lewis was significantly
Figure 3. Effect of NO regulation on the growth of T. gondii in rat and mouse macrophages. (Top) RT-PCR for iNOS mRNA expression level
in mouse (A) and rat (D) peritoneal macrophages treated with LPS+IFN-c or L-NAME. (Bottom) Amplicons were densitometrically quantified; bars
represent relative amounts of amplified iNOS mRNA normalized against GAPDH in mouse (A) and rat (D) macrophages. Comparison of NO
production, measured by the Griess reaction, in mouse (B) and rat (E) macrophages treated with LPS+IFN-c or L-NAME. Number of T. gondii per 100
macrophages counted 24 hrs after infection in mouse (C) and rat (F) cells. ND: not detectable. Mean6SEM and significant differences (* p,0.05, **
p,0.01, *** p,0.001) (n = 4).
doi:10.1371/journal.pone.0035834.g003
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higher than those from Lewis rats but much lower than those from
BN rats. Our results also showed that the iNOS expression level
and NO concentration in the peritoneal macrophages from the F1
progeny of BN6Lewis was significantly lower than in Lewis rats,
but higher than in BN rats. When considering the studies on the
Toxo1 locus [27], we note that the iNOS gene is also located on
chromosome 10 (GenBank #24599). From our studies, we suggest
that the Toxo1 locus is likely to be associated with the iNOS gene
although additional research will be needed in order to ascertain
this matter.
Why is NO so much higher in rat macrophages than in mice? It
is well documented that iNOS is responsible for most of the NO
production from L-arginine in rodent macrophages [40]. Arginase
shares the same substrate (i.e. L-arginine) with iNOS and has
crucial roles in the host immune system [41,42]. Arginase 1 (Arg 1)
has been induced in alternatively activated macrophages (AAMs)
and function in part to suppress NO production in intracellular
infection [33]. Arginase 1 hydrolyzes L-arginine to urea and L-
ornithine, which are the precursors for the synthesis of polyamines
via the ornithine decarboxylase (ODC) pathway. Polyamines
promote parasite proliferation due to their inhibition of iNOS
expression [43] and because of the inability of T. gondii to convert
arginine to putrescine, polyamines from the host cell are extremely
important course for the growth of this parasite [44]. In fact,
because arginase utilizes the same substrate as iNOS, arginase
activity can decrease NO production by reducing the availability
of L-arginine to iNOS [19,22,23,45].
In order to understand the reason behind the distinctive
differences in NO concentration between non-activated peritoneal
macrophages of rat and mouse, we analyzed the gene and protein
expression of Arg 1 in the peritoneal macrophages from rat and
mouse strains. The higher expression level of Arg 1 was
accompanied by lower expression of iNOS in the macrophages
of mouse strains and, vice versa, lower expression of Arg 1 was
accompanied by higher expression of iNOS in the rat peritoneal
macrophages. Arginase activity in the peritoneal macrophages of
BN6Lewis F1 progeny is higher than that in Lewis but lower than
that in BN rats. When arginase activity in mouse peritoneal
macrophages was reduced by the inhibitor norNOHA (Nv-
hydroxy-nor-L-arginine), NO production was significantly in-
creased, resulting in the growth inhibition of T. gondii. It is likely
that substrate competition of these enzymes occurring in the
rodent peritoneal macrophages regulates the growth of T. gondii by
means of NO concentration in the cells. The higher activity of Arg
1 in mouse macrophages will use more arginine to produce more
polyamines, which promote the growth of T. gondii [44,46]. In rat
macrophages, most of the arginine is used by high iNOS activity to
produce more NO [24], which is a harmful molecule for the
parasites within the cells. By knocking out the arginase gene from
mouse strains, it has been demonstrated that the deletion of Arg 1
Figure 4. Animal survival curves and detection of parasites after T. gondii infection. (A) Survival curve of rat (SD, Lewis, Wistar, F344, and
BN) and mouse (Swiss, BALB/c, NIH, and C57BL/6) after 106 (for rat) and 105 (for mouse) RH tachyzoite intraperitoneal infection for 60 days. (B)
Detection of T. gondii by PCR, microscopy and mouse infection using brain, heart, liver, spleen, lung, and kidney.
doi:10.1371/journal.pone.0035834.g004
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significantly prolongs the survival of hosts during T. gondii and
Mycobacterium tuberculosis infections, because more arginine is
available to produce NO [33].
In conclusion, our results demonstrate that the different
expression levels of iNOS and Arg 1 in rodent peritoneal
macrophages work together to determine the resistance and
susceptibility to T. gondii RH strain infection. High iNOS and low
Arg 1 expression level in the rat peritoneal macrophages result in
the natural resistance to T. gondii infection. In contrast, low iNOS
and high Arg 1 expression level in mouse peritoneal macrophages
allow the growth of T. gondii. The present study highlights the NO-
dependent immunity to T. gondii and the opposing roles of iNOS
and Arg 1 to the growth of the parasite in rat macrophages. These
findings provide insights towards understanding the mechanisms
used by mammals against infections of T. gondii and other
intracellular pathogens. Furthermore, the differences in iNOS and
Arg 1 activity between individual inbred lines of mice and rats
indicates that this mechanism may also account for variation in
susceptibility of individuals within natural populations of mam-
malian species. Further study of these processes may lead to a
better understanding of the mechanisms of parasite virulence and
host resistance. Such an understanding is likely to improve our
ability to develop drugs against T. gondii.
Materials and Methods
Ethics Statement
All animals were treated in strict accordance to the guidelines
for the Laboratory Animal Use and Care from Chinese CDC and
the Rules for Medical Laboratory Animals (1998) from Ministry of
Health, China, under the protocols approved by National Institute
for Communicable Disease Control and Prevention and Labora-
tory Animal Use and Care Committee of Sun Yat-Sen University
under the licenses of 2010CB53000.
Animals
We used five rat strains, Sprague Dawley (SD), Wistar, Brown
Norway (BN), Fischer 344 (F344) and Lewis (6 to 8 weeks old,
weight 150,200 g) and 4 mouse strains, BALB/c, C57BL/6, NIH
and Swiss mice (6 to 8 weeks old, weight 25,30 g). All BN, F344
and Lewis were purchased from Vital River Laboratories (Beijing,
China); the other rat and mouse strains were purchased from the
Experimental Animal Center of Sun Yat-Sen (Zhongshan)
University. All animals were maintained in a pathogen-free room
at the School of Life Sciences, Sun Yat-Sen University following
the university policy.
Figure 5. Arginase-1 expression and arginase activity in rat and mouse peritoneal macrophages. (A) (Top) RT-PCR analysis for the
expression of arginase-1 mRNA. (Bottom) Amplicons densitometrically quantified; bars represent the relative amounts of amplified arginase-1 mRNA
normalized against GAPDH. (B) (Top) Western blotting analysis for expression of arginase-1 protein. (Bottom) Protein bands densitometrically
quantified and relative amounts of amplified iNOS protein normalized against tubulin. (C) Arginase activity measured by a colorimetric assay; enzyme
activity is the output of urea secreted from lysed macrophages. Error bars indicate standard deviations of the measured values (n = 3). One-way
ANOVA test to compare any significant differences of arginase activity among all kinds of groups and different letters above the same bar type
indicate significant difference (Duncan, p,0.05).
doi:10.1371/journal.pone.0035834.g005
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BN6 Lewis F1 progeny
BN (R)6 Lewis (=) F1 hybrid rats were generated in our
laboratory, which were viably fertile, normal in size and did not
display any behavioral or physical abnormalities. F1 individuals
were identified by a black and white pattern on the underside.
Parasites
The Toxoplasma gondii RH-GFP strain was kindly provided by
Dr. X.N. Xuan of the National Research Center for Protozoan
Diseases, Obihiro University, Obihiro, Japan, generated as
described [47]. For the purification of tachyzoites, T. gondii and
host cell debris were harvested from the peritoneal cavities of
BALB/c mice by injection of ice cold D-Hanks on day 3 after
infection. The solution containing T. gondii was centrifuged at
406g for 5 min at 4uC to discard host cells and fragments. The
supernatant was centrifuged at 13506g for 10 min at 4uC, and
then suspended in RPMI-1640 medium (GIBCO Laboratories,
USA) with 10% fetal bovine serum (FBS) for further use after
counted.
Peritoneal macrophage isolation and cultivation
Animals, sacrificed by carbon dioxide (CO2), were injected
intraperitoneally with 5 ml (mouse) or 15 ml (rat) ice cold D-
Hank’s solution containing 100 U of penicillin and 100 mg of
streptomycin per ml and then peritoneal cells were harvested and
separated by centrifugation at 2506g for 10 min at 4uC. The cells
were washed by D-Hank’s solution and centrifuged with the same
procedure. Finally, cells were suspended in RPMI-1640 medium
with 10% FBS and left to adhere for 2 hrs at 37uC in an incubator
containing 5% CO2 and 95% air. Non-adherent cells were
removed and fresh medium was added. Macrophages were
cultured overnight and then used for further experiments. Rat
peritoneal macrophages were incubated with or without lipopoly-
saccharide (LPS; 10 mg/ml, Sigma, St. Louis, USA) plus IFN-c
(1 mg/ml, Sigma, USA) or with the NOS specific inhibitor Nv –
Figure 6. Analysis of iNOS and arginase expression and growth of T. gondii in BN, Lewis and BN6Lewis F1 hybrid macrophages. (A)
(left) RT-PCR for expression of iNOS and arginase-1 mRNA. Amplicons were densitometrically quantified; bars represent relative amounts of amplified
iNOS (middle) and arginase-1 (right) mRNA normalized against GAPDH. (B) NO production measured by the Griess reaction at 12 hrs, 24 hrs, and
48 hrs after infection. (C) Arginase activity measured by a colorimetric assay; enzyme activity is the output of urea secreted from lysed macrophages.
(D) Number of T. gondii per 100 macrophages at 1 hr, 12 hrs and 24 hrs after infection. Mean6 SEM and significant differences (* p,0.05, ** p,0.01,
*** p,0.001) (n = 3).
doi:10.1371/journal.pone.0035834.g006
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nitro-L-arginine methyl ester (L-NAME; 10 mM; Sigma, St.
Louis, USA); mouse macrophages were incubated alone, or
treated with LPS (10 mg/ml) plus IFN-c (1 mg/ml) or with the
arginase inhibitor Nv-hydroxy-nor-L-arginine (nor NOHA)
(500 mM, Sigma, USA) plus LPS (0.5 mg/ml).
Parasite infection and detection in animals
Five rat strains (SD, Wistar, BN, F344 and Lewis) and 4 mouse
strains (Swiss, BALB/c, C57BL/6 and NIH) were injected
intraperitoneally with 106 (for rat) or 105 (for mice, taking into
account the body size of the mouse compared to the rat) T. gondii
RH strain tachyzoites, then observed to construct an animal
survival curve. Animal organs (brain, heart, liver, spleen, lung and
kidney) were isolated, 4 days (mouse, before death) and 60 days
(rat) after infection, for detection of T. gondii through microscopy,
mouse infection and PCR detection. For the mouse infection,
organs (brain, heart, liver, spleen, lung and kidney) from T. gondii
infected rat 60 days after infection were collected and homo-
genated respectively, then 0.2 ml homogenate of each organ was
injected intraperitoneally to BALB/c mouse. 5 mice were used for
each organ homogenate. For the PCR detection, total DNA was
extracted from animal organs including brain, heart, liver, spleen,
lung and kidney according to the manufacturer’s instructions. A
529 bp fragment was amplified from the DNA template using the
following primers [48]: 59-CGCTGCAGGGAGGAAGAC-
GAAAGTTG-39 and 59-CGCTGCAGACACAGTGCATCTG-
GATT-39. Amplified DNA products were separated on 1%
agarose gel and photographed using an electronic documentation
system (Biostep, Germany) after staining with ethidium bromide.
Determination of T. gondii intracellular multiplication
Rat or mouse macrophages were challenged with T. gondii RH
strain tachyzoites at ratio 1:1 (T. gondii/macrophage). Extracellular
T. gondii were then washed out after 1 hr incubation together, at
which the time point was defined as 0 hr for the start of the
experiment. Thereafter, the cells were observed with an inverted
fluorescence microscope or stained with Giemsa at the desired
time. The numbers of T. gondii were counted in 100 host
macrophages and an average determined.
Measurement of iNOS and arginase activity
Nitrite content as a reflection of NO production was determined
by the Griess reaction as described [25]. Briefly, 100 ml
supernatant or standard solution (NaNO2) were incubated in
triplicate with 100 ml of Griess reagent (0.5%sulfanilamide, 0.05%
naphthyldiamine dihydrochloride in 5% H3PO4) for 10 min. The
plates were read at 550 nm in an ELISA reader (Multiskan MK3,
Thermo Labsystems, Finland).
Figure 7. Effect of arginase inhibitor norNOHA on the NO production and T. gondii growth in BALB/c mouse peritoneal
macrophages. (A) Arginase activity in mouse peritoneal macrophages treated with LPS (0.5 mg/ml) only or LPS (0.5 mg/ml)+norNOHA (500 mM) for
24 hrs, measured by a colorimetric assay; enzyme activity is the output of urea secreted from lysed macrophages. (B) NO production measured by the
Griess reaction in mouse macrophages treated with LPS (0.5 mg/ml) only or LPS (0.5 mg/ml)+norNOHA (500 mM) for 24 hrs. (C) Number of T. gondii per
100 macrophages counted at 24 hrs after infection in LPS (0.5 mg/ml) only or LPS (0.5 mg/ml)+norNOHA (500 mM) treated mouse macrophages. Mean
6 SEM and significant differences (*p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0035834.g007
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Arginase activity of purified macrophage was measured by a
colorimetric method as described [49]. Briefly, 10 mM MnCl2 and
0.5 M L-arginine were successively added to macrophage lysates
for 1 hr at 37uC. The reaction was stopped by addition of an acid
solution (H2SO4:H3PO4:H2O = 1:3:7), and the urea generated by
arginase was analyzed by addition of a-isonitrosopropiophenone
at 100uC for 45 min. The colored product was quantified by
absorption at 550 nm in an ELISA reader. Arginase activity was
determined as the amount of urea produced from total protein of
peritoneal macrophages.
mRNA analysis
Total RNA from treated and non-treated macrophages was
extracted using Trizol Reagent (Invitrogen, Carlsbad, USA)
according to the manufacturer’s instructions. Total RNA was
converted to cDNA using a set of oligo (dT) primer and
SuperScriptTM III First-Strand Synthesis System (Invitrogen,
Carlsbad, USA). cDNA (1 mg) was used as a template for
amplifying iNOS, arginase-1 and GAPDH (as internal standard)
genes by PCR using the following primers: arginase-1, 59-AAG
AAA AGG CCG ATT CAC CT-39 and 59-CAC CTC CTC
TGC TGT CTT CC-39, 201 bp; rat-iNOS, 59-CTA CCT ACC
TGG GGA ACA CCT GGG-39 and 59-GGA GGA GCT GAT
GGA GTA GTA GCG G-39, 442 bp; mouse-iNOS, 59-GCC
TCG CTC TGG AAA GA-39 and 59-TCC ATG CAG ACA
ACC TT-39, 499 bp; GADPH, 59-AAT GCK TCC TGY ACC
ACC AAC TGC-39 and 59-TTA GCC AWA TTC RTT GTC
RTA CCA GG-39, 513 bp [10]. For semiquantitative PCR, the
cycle was: 94uC for 1 min, 60uC for 1.5 min, and 72uC for
1.8 min. For arginase-1, rat-iNOS, mouse-iNOS, 27 cycles were
used, but for GAPDH, only 20 cycles. Amplified DNA products
were separated on 1% agarose gel and photographed using an
electronic documentation system (Biostep, Germany) after staining
with ethidium bromide. Signal intensity was quantified using Gelix
One software.
Western Blotting
Cells were lysed in SDS loading buffer, fractionated in SDS-
PAGE and transferred onto immunoblot polyvinylidene difluoride
membrane (Pall, USA). The membrane was probed using rabbit
polyclonal iNOS antibody (Thermo, USA) and rabbit polyclonal
arginase-1 antibody (Santa Cruz, USA). b-tubulin was stained with
antibody (NOVUS, USA) as control. Horseradish peroxidase-
labeled secondary antibodies (Cell Signaling, USA) and DAB
(3,39,5,59-tetramethylbenzidine) Detection Kit (Tiangen, China)
were used for antibody detection. Signal intensity was quantified
using Gelix One software.
Statistical analysis
Results are expressed as mean 6 SEM. Multiple data
comparisons were derived by one-way ANOVA using SPSS 13.0
software (SPSS Inc., Chicago, USA). We used a one-way ANOVA
test (Duncan test, p,0.05) to compare any significant differences
among all kinds of groups for the same time point. Student’s t-test
was used to compare differences between two unpaired samples
and statistical differences were designated by *(p,0.05), **
(p,0.01) and *** (p,0.001).
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